Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,413 | 157 | 91.4% |
| Education | $322.96 | 4 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $702.05 | 33 | $0 (2024) |
| GENZYME CORPORATION | $587.33 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $415.33 | 35 | $0 (2024) |
| Lilly USA, LLC | $292.81 | 13 | $0 (2024) |
| Dermavant Sciences, Inc. | $281.47 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $275.66 | 4 | $0 (2024) |
| Amgen Inc. | $220.63 | 11 | $0 (2024) |
| UCB, Inc. | $192.93 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $138.70 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $113.98 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,765 | 82 | ABBVIE INC. ($346.98) |
| 2023 | $1,392 | 63 | ABBVIE INC. ($326.43) |
| 2022 | $418.95 | 12 | GENZYME CORPORATION ($221.88) |
| 2021 | $159.02 | 4 | Regeneron Healthcare Solutions, Inc. ($99.99) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.14 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.10 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $11.00 | General |
| 11/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $4.92 | General |
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Immunology | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $33.39 | General |
| Category: Immunology | ||||||
| 09/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $5.03 | General |
| Category: Dermatology | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: Dermatology | ||||||
| 09/06/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Immunology | ||||||
| 08/29/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DERMATOLOGY | ||||||
| 08/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,460 | 2,650 | $540,325 | $98,136 |
| 2022 | 13 | 1,584 | 2,810 | $589,285 | $115,251 |
| 2021 | 13 | 1,358 | 2,229 | $478,530 | $93,865 |
| 2020 | 11 | 431 | 527 | $44,821 | $25,547 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 413 | 715 | $139,425 | $36,027 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 179 | $40,275 | $12,345 | 30.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 250 | 381 | $114,300 | $12,206 | 10.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 118 | 163 | $81,500 | $10,813 | 13.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 149 | 182 | $63,700 | $9,820 | 15.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 118 | 143 | $21,450 | $4,239 | 19.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 158 | 726 | $36,300 | $3,043 | 8.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $10,500 | $2,569 | 24.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 22 | 23 | $8,050 | $1,636 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,875 | $1,536 | 31.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 14 | $5,250 | $1,446 | 27.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 40 | $7,000 | $1,276 | 18.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $3,150 | $609.05 | 19.3% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 13 | $4,550 | $571.84 | 12.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 406 | 688 | $134,160 | $36,601 | 27.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 184 | $41,400 | $13,914 | 33.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 223 | 358 | $107,400 | $12,237 | 11.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 116 | 184 | $92,000 | $12,140 | 13.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 158 | 191 | $66,850 | $11,183 | 16.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 159 | 159 | $39,750 | $9,432 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $18,850 | $5,825 | 30.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 144 | 741 | $37,050 | $3,175 | 8.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 87 | 100 | $15,000 | $3,000 | 20.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 18 | 23 | $8,625 | $2,319 | 26.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 23 | 24 | $8,400 | $2,000 | 23.8% |
About Chelsey Gray, P.A
Chelsey Gray, P.A is a Medical healthcare provider based in Jamestown, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2010. The National Provider Identifier (NPI) number assigned to this provider is 1306157326.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Chelsey Gray, P.A has received a total of $3,736 in payments from pharmaceutical and medical device companies, with $1,765 received in 2024. These payments were reported across 161 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,413).
As a Medicare-enrolled provider, Gray has provided services to 4,833 Medicare beneficiaries, totaling 8,216 services with total Medicare billing of $332,798. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Jamestown, NY
- Active Since 06/24/2010
- Last Updated 08/21/2018
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1306157326
Products in Payments
- DUPIXENT (Biological) $837.98
- SKYRIZI (Biological) $556.20
- COSENTYX (Drug) $295.44
- TALTZ (Drug) $286.14
- VTAMA (Drug) $281.47
- Otezla (Drug) $220.63
- Bimzelx (Biological) $154.95
- TREMFYA (Drug) $138.70
- RINVOQ (Biological) $137.15
- Sotyktu (Drug) $113.98
- Impella (Device) $85.85
- EUCRISA (Drug) $78.41
- OPZELURA (Drug) $59.95
- ILUMYA (Biological) $52.51
- Zoryve (Drug) $45.40
- Cimzia (Drug) $37.98
- SPEVIGO (Drug) $23.00
- FreeStyle Libre 2 (Device) $19.42
- PREMARIN (Drug) $18.88
- HUMIRA (Biological) $8.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Jamestown
Connie Scarpine, Pa, PA
Medical — Payments: $12,451
Gust Verleni, Pa, PA
Medical — Payments: $8,852
Mrs. Julie Coppersmith, Pa, PA
Medical — Payments: $2,325
Carrie Bauer, Pa, PA
Medical — Payments: $2,103
Ashley Michaels, Pa, PA
Medical — Payments: $1,775
Chad Chitester, P.a, P.A
Medical — Payments: $1,685